Increased exercise tolerance after oral diltiazem, a calcium antagonist, in angina pectoris
- PMID: 6781321
- DOI: 10.1016/0002-8703(81)90656-6
Increased exercise tolerance after oral diltiazem, a calcium antagonist, in angina pectoris
Abstract
Effects of diltiazem, a recently introduced calcium antagonist, on exercise performance were studied in nine coronary disease patients with effort angina. The duration of exercise before the onset of angina and the time to the onset of ischemic ST depression 2 hours after 90 mg of oral diltiazem were compared with those 2 hours after oral placebo and a few minutes after 0.3 mg of sublingual nitroglycerin. Diltiazem prolonged the duration of exercise in all nine patients (average 2.5 minutes, p less than 0.001) and delayed the onset of ischemic ST depression (average 2.4 minutes, p less than 0.001). The increment of the duration of exercise and the time to the onset of ischemic ST depression following 90 mg of oral diltiazem were almost equivalent to that following sublingual nitroglycerin. These results in fixed coronary atherosclerosis indicate the clinical antianginal efficacy of diltiazem which persists for at least 2 hours after oral administration.
Similar articles
-
Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris.Circulation. 1982 Jul;66(1):23-8. doi: 10.1161/01.cir.66.1.23. Circulation. 1982. PMID: 7083512 Clinical Trial.
-
The beneficial effect of diltiazem on exercise-induced ST depression, measured by body surface mapping, in stable effort angina pectoris.Clin Ther. 1982;5(1):49-60. Clin Ther. 1982. PMID: 7127369
-
Excessive reduction in peripheral resistance during exercise and risk of orthostatic symptoms with sustained-release nitroglycerin and diltiazem treatment of angina.Am Heart J. 1985 May;109(5 Pt 1):1020-6. doi: 10.1016/0002-8703(85)90244-3. Am Heart J. 1985. PMID: 3922207 Clinical Trial.
-
Diltiazem: a review of its clinical efficacy and use.Drug Intell Clin Pharm. 1982 May;16(5):371-9. doi: 10.1177/106002808201600503. Drug Intell Clin Pharm. 1982. PMID: 7044736 Review. No abstract available.
-
[Diltiazem hydrochloride: synthetic and pharmacological studies and development].Yakugaku Zasshi. 1988 Aug;108(8):716-32. doi: 10.1248/yakushi1947.108.8_716. Yakugaku Zasshi. 1988. PMID: 3073210 Review. Japanese. No abstract available.
Cited by
-
Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris.Cardiovasc Drugs Ther. 1987;1(1):81-7. doi: 10.1007/BF02125837. Cardiovasc Drugs Ther. 1987. PMID: 3154312 Clinical Trial.
-
Immediate and long-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.Br J Clin Pharmacol. 1985;20 Suppl 1(Suppl 1):158S-162S. doi: 10.1111/j.1365-2125.1985.tb05159.x. Br J Clin Pharmacol. 1985. PMID: 4027147 Free PMC article.
-
Role of calcium channel blockers in experimental exercise-induced ischemia.Cardiovasc Drugs Ther. 1988 Jan;1(5):503-12. doi: 10.1007/BF02125733. Cardiovasc Drugs Ther. 1988. PMID: 3154679 Review.
-
Diltiazem. A review of its pharmacological properties and therapeutic efficacy.Drugs. 1985 May;29(5):387-454. doi: 10.2165/00003495-198529050-00001. Drugs. 1985. PMID: 3891302 Review.
-
Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID.Cardiovasc Drugs Ther. 1995 Apr;9(2):319-30. doi: 10.1007/BF00878677. Cardiovasc Drugs Ther. 1995. PMID: 7662599 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical